Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Atea Pharmaceuticals (AVIR) Tax Provisions (2021 - 2022)

Atea Pharmaceuticals (AVIR) has 2 years of Tax Provisions data on record, last reported at $123000.0 in Q4 2022.

  • For Q4 2022, Tax Provisions fell 97.0% year-over-year to $123000.0; the TTM value through Dec 2022 reached -$3.6 million, down 120.63%, while the annual FY2025 figure was -$6.2 million, 766.16% down from the prior year.
  • Tax Provisions reached $123000.0 in Q4 2022 per AVIR's latest filing, up from -$3.8 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $7.2 million in Q2 2021 and bottomed at -$3.8 million in Q3 2022.